{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05403801",
            "orgStudyIdInfo": {
                "id": "21-719"
            },
            "organization": {
                "fullName": "Dana-Farber Cancer Institute",
                "class": "OTHER"
            },
            "briefTitle": "STAMP+CBT mHealth for Cancer Pain",
            "officialTitle": "Harnessing Mobile Technology to Deliver Tailored, Brief Pain-CBT for Advanced Cancer Patients on Opioids for Pain",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "stamp-cbt-mhealth-for-cancer-pain"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-07-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2023-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-05-26",
            "studyFirstSubmitQcDate": "2022-05-31",
            "studyFirstPostDateStruct": {
                "date": "2022-06-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-11-17",
            "lastUpdatePostDateStruct": {
                "date": "2022-11-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Desiree R. Azizoddin PsyD",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Dana-Farber Cancer Institute"
            },
            "leadSponsor": {
                "name": "Dana-Farber Cancer Institute",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Palliative Care Research Center (NPCRC)",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to test whether a mobile application developed to help people with cancer pain is useful and helpful to patients with cancer.",
            "detailedDescription": "This research study involves the use of a smartphone app at home in addition to surveys and potentially an interview at the end of the study.\n\nThe research study procedures include screening for eligibility, study interventions include surveys at the beginning of the study, after 4 weeks, and after 6 weeks and use of the smartphone app.\n\nParticipants will be on this research study for up to 6 weeks.\n\nIt is expected that about 15 people will take part in this research study\n\nThis research study is a Feasibility Study, which is the first-time investigators are examining this mobile application meant to help participant to learn behavioral techniques to manage cancer pain. The purpose is to make sure the app is usable and helpful for patients with cancer, and to get feedback about patient experiences after using the app for four weeks."
        },
        "conditionsModule": {
            "conditions": [
                "Active Cancer",
                "Active Cancer Treatment",
                "Advanced Cancer",
                "Palliative Care",
                "Chronic Pain Due to Cancer"
            ],
            "keywords": [
                "Active cancer",
                "Active cancer treatment",
                "Advanced Cancer",
                "Palliative care",
                "Chronic Pain due to Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 15,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "STAMP+CBT PILOT",
                    "type": "EXPERIMENTAL",
                    "description": "Patients in this Pilot Cohort will be in the research study for 6 weeks total including:\n\n* a 4-week intervention period and 2-week post intervention period.\n* Patients will use the app for a total of 4 weeks (4-week intervention period), and will complete surveys at baseline, 4 weeks (end of intervention period), and at 6 weeks (end of 2-week post intervention period).",
                    "interventionNames": [
                        "Behavioral: STAMP+CBT application"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "STAMP+CBT application",
                    "description": "Use the STAMP+CBT mobile app for 4 weeks (intervention period, 4 weeks for content introduction, extended 2 weeks for review of content if patient's request this",
                    "armGroupLabels": [
                        "STAMP+CBT PILOT"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Overall Intervention Adherence Rate",
                    "description": "\\>70% of subjects complete \\>4 of the 6 pain-CBT modules and patients will complete 60% of surveys by the end of 4 weeks (completion of the 4-week intervention study period)(completion of the 4-week intervention study period)",
                    "timeFrame": "4 Weeks"
                },
                {
                    "measure": "Acceptability Rate",
                    "description": "\\>80% of the acceptability items are rated 4 or higher/5; lower ratings will lead to app refinements",
                    "timeFrame": "4 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Study Accrual Rate",
                    "description": "15 patients will be enrolled to the trial within 6 months",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Study retention",
                    "description": "60% of patients who enroll to the app with complete app use at the end of the 4 weeks and surveys at 4 and 6 weeks after enrollment",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "COMPREHENSIVE ENDPOINT",
                    "description": "Overall acceptability will be determined based on composite evaluation of acceptability ratings using the e-Acceptability scale, app content completion rates, and qualitative patient feedback.",
                    "timeFrame": "6 Weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n- PILOT COHORT\n\n* Age \u2265 18 years\n* Patients diagnosed with an active cancer diagnosis, either undergoing active cancer treatment or receiving treatment for an advanced cancer or are receiving palliative care\n* Treatment managed at participating clinic (DFCI outpatient palliative care, gastrointestinal cancer center, and DFCI satellite clinic Merrimack Valley or Londonderry)\n* Chronic pain related to cancer or treatment (\\> pain score of 4)\n* Has an active prescription for at least one opioid medication to treat their cancer pain (i.e. not for post-surgical pain)\n* Own a compatible smartphone (android) or is willing to use an android device provided by the study team\n* Completes baseline survey\n\nExclusion Criteria:\n\n* Patients in survivorship: patients who have completed their treatment regimens, are not actively receiving treatment for an advanced cancer, or have a cancer that is in remission\n* Cognitive impairment that would interfere with study participation, as judged by treating clinician\n* Inability to speak English: the intervention has not yet been translated to Spanish\n* History of opioid use disorders\n* Enrolled in hospice\n* Currently hospitalized\n* Use of transmucosal fentanyl, given safety concerns and ongoing risk mitigation program required to prescribe these (TIRF REMS).\n* Pain primarily related to a recent surgery",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Desiree Azizoddin, PsyD",
                    "role": "CONTACT",
                    "phone": "(626) 826-7984",
                    "email": "Desiree_Azizoddin@DFCI.Harvard.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Desiree Azizoddin, PsyD",
                    "affiliation": "Dana-Farber Cancer Institute",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Dana Farber Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Desiree R Azizoddin, PsyD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Desiree R Azizoddin, PsyD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Dana-Farber at Merrimack Valley",
                    "status": "RECRUITING",
                    "city": "Methuen",
                    "state": "Massachusetts",
                    "zip": "01844",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Frederick Briccetti, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Frederick Briccetti, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.7262,
                        "lon": -71.19089
                    }
                },
                {
                    "facility": "Dana-Farber at Londonderry",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Londonderry",
                    "state": "New Hampshire",
                    "zip": "03053",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Pedro Sanz-Altamira, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Pedro Sanz-Altamira, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.86509,
                        "lon": -71.37395
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to Sponsor Investigator or designee. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP"
            ],
            "timeFrame": "Data can be shared no earlier than 1 year following the date of publication",
            "accessCriteria": "Contact the Belfer Office for Dana-Farber Innovations (BODFI) at innovation@dfci.harvard.edu"
        }
    },
    "annotationSection": {
        "annotationModule": {
            "unpostedAnnotation": {
                "unpostedResponsibleParty": "Desiree R. Azizoddin PsyD, Principal Investigator, Dana-Farber Cancer Institute",
                "unpostedEvents": [
                    {
                        "type": "RELEASE",
                        "date": "2023-08-03"
                    },
                    {
                        "type": "RESET",
                        "date": "2024-03-07"
                    }
                ]
            }
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "submissionTracking": {
                "estimatedResultsFirstSubmitDate": "2023-08-03",
                "submissionInfos": [
                    {
                        "releaseDate": "2023-08-03",
                        "resetDate": "2024-03-07"
                    },
                    {
                        "releaseDate": "2024-03-13"
                    }
                ]
            }
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000059350",
                    "term": "Chronic Pain"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010146",
                    "term": "Pain"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M29442",
                    "name": "Chronic Pain",
                    "asFound": "Chronic Pain",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M1091",
                    "name": "Cancer Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}